Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NTRA
NTRA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NTRA News
Natera Showcases New Prospera Test Data at American Transplant Congress
2d ago
Newsfilter
NTRA Stock Shows Potential for Breakout
3d ago
CNBC
U.S. Government May Challenge IARC Cancer Assessments
Jun 08 2026
seekingalpha
JGRO Stock Price Analysis and ETF Dynamics
Jun 05 2026
NASDAQ.COM
Stanley Druckenmiller Invests in Natera
Jun 03 2026
Fool
Natera Partners with Diakonos to Evaluate New Therapy
May 29 2026
Newsfilter
Natera Initiates SIGNAL-ER 101 Study for Early-Stage Breast Cancer
May 28 2026
NASDAQ.COM
Natera Launches SIGNAL-ER 101 Trial for Breast Cancer Treatment De-escalation
May 28 2026
Newsfilter
Natera Enhances Panorama NIPT with Low Fetal Fraction Technology
May 26 2026
Newsfilter
FDA Approves Tecentriq for Bladder Cancer Treatment
May 15 2026
seekingalpha
Natera Receives FDA Approval for Personalized MRD Testing
May 15 2026
Newsfilter
Natera Reports Q1 Results Exceeding Revenue Expectations with 38.8% Growth
May 12 2026
Yahoo Finance
Natera Reports 39% Revenue Growth in Q1 2026
May 08 2026
seekingalpha
Natera Q1 Earnings Beat Expectations with Strong Revenue Growth
May 07 2026
seekingalpha
Strait of Hormuz Reopening Boosts Healthcare Stocks
Apr 18 2026
Yahoo Finance
Latest Rating Changes on Wall Street
Apr 14 2026
CNBC
Show More News
